HomeRNTX • NASDAQ
add
Rein Therapeutics Inc
Previous close
$1.21
Day range
$1.11 - $1.33
Year range
$1.02 - $2.38
Market cap
34.77M USD
Avg Volume
89.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.96M | -31.71% |
Net income | -31.97M | 22.00% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.96M | 31.71% |
Effective tax rate | 2.18% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.22M | -75.01% |
Total assets | 24.16M | -61.15% |
Total liabilities | 7.24M | -7.16% |
Total equity | 16.92M | — |
Shares outstanding | 28.04M | — |
Price to book | -1.19 | — |
Return on assets | -25.42% | — |
Return on capital | -31.37% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -31.97M | 22.00% |
Cash from operations | -3.22M | 33.08% |
Cash from investing | — | — |
Cash from financing | 2.40M | 240,400.00% |
Net change in cash | -833.00K | 82.69% |
Free cash flow | -1.77M | 44.10% |
About
Founded
2001
Headquarters
Website
Employees
10
